Known targets — ChEMBL curated mechanism
ABL1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB2AGTR1BCL2BCL2A1BCL2L1BCL2L10BCL2L2BCRBRAFCHRM1CHRNA10CHRNA9DRD1DRD2DRD3DRD4DRD5EGFRF2FLT1FLT4GCKGHSRGNRHRGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHTR1AHTR1BHTR1DHTR2AHTR2CHTR3AIDH2KDRKITMAOBMCL1MTTPPP4HBPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PIKFYVEROCK1ROCK2SLC18A2SLC6A2SLC6A3SLC6A4TACR1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8gyrAgyrBparCparEpol
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABL1 known ✓ | P00519 | 1/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.56 |
| ▸ | GAA | P10253 | 1/20 | 0.56 |
| ▸ | CA12 | O43570 | 10/20 | 0.55 |
| ▸ | CA1 | P00915 | 10/20 | 0.55 |
| ▸ | CA2 | P00918 | 10/20 | 0.55 |
| ▸ | CA4 | P22748 | 10/20 | 0.55 |
| ▸ | CA7 | P43166 | 10/20 | 0.55 |
| ▸ | CA9 | Q16790 | 10/20 | 0.55 |
| ▸ | TRPV1 | Q8NER1 | 7/20 | 0.55 |
| ▸ | SYK | P43405 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | DPP4 | P27487 | 1/20 | 0.52 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.52 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.52 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3030259 | 0.90 | KDM4E (0.61) | KDM4EABL1LMNAGPR119CA12 | |
| SCHEMBL1349588 | 0.90 | KDM4E (0.61) | KDM4EABL1LMNAGPR119CA12 | |
| SCHEMBL785166 | 0.90 | KDM4E (0.61) | KDM4EABL1LMNAGPR119CA12 | |
| Hydrochloric Acid SCHEMBL23167687 | 0.89 | KDM4E (0.60) | KDM4EABL1LMNAGPR119CA12 | |
| Hydrochloric Acid SCHEMBL23167691 | 0.89 | KDM4E (0.60) | KDM4EABL1LMNAGPR119CA12 | |
| SCHEMBL1351273 | 0.82 | KDM4E (0.68) | KDM4EABL1LMNAGPR119GAA | |
| Hydrochloric Acid SCHEMBL2001717 | 0.81 | KDM4E (0.67) | KDM4EABL1LMNAGPR119GAA | |
| Hydrochloric Acid SCHEMBL29773190 | 0.81 | KDM4E (0.67) | KDM4EABL1LMNAGPR119GAA | |
| Hydrochloric Acid SCHEMBL2121386 | 0.81 | KDM4E (0.67) | KDM4EABL1LMNAGPR119GAA | |
| Mandelic Acid SCHEMBL7251915 | 0.79 | LMNA (0.54) | KDM4EABL1LMNACA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030069423-A1 | Novel processes for the preparation of adenosine compounds and intermediates thereto | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2003-04-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030069423-A1 | Novel processes for the preparation of adenosine compounds and intermediates thereto | ADK, ADORA2A, ADORA1 | ABL1 3212/4885KDM4E 3423/4885LMNA 569/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.